RxDoctor Payments Data

Carolina Nelson, MD

Family Medicine · St Petersburg, FLNPI 1003228131

Payments from drug & device makers

$5,699in general payments, 2019–2025

Across 298 payments — averaging $19.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • AstraZeneca$628
  • Boehringer Ingelheim$562
  • AbbVie$493
  • Takeda Pharmaceuticals U.S.A., Inc.$383
  • GSK$374
  • plus $2K from 20 others

What the payments were for

  • Food & beverage$5,675100%
  • Education$230%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,699 in reported general payments places this provider in the 85th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$117,200
Medicare patients
399
Services billed
1,109

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide85$89,985
OzempicSemaglutide63$87,542
JardianceEmpagliflozin51$72,948
TrulicityDulaglutide60$67,661
EliquisApixaban61$58,690
MyrbetriqMirabegron65$37,429
RybelsusSemaglutide14$23,080
LinzessLinaclotide15$20,035
WegovySemaglutide11$19,254
FarxigaDapagliflozin Propanediol14$19,006
XareltoRivaroxaban11$15,960
Breztri AerosphereBudesonide/Glycopyr/Formoterol17$11,020
Aimovig AutoinjectorErenumab-Aooe11$8,147
BreynaBudesonide/Formoterol Fumarate25$6,862
SynthroidLevothyroxine Sodium75$5,918

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$301$157,645145 claims
Novo NordiskOzempic, Rybelsus, Wegovy$1,304$129,87688 claims
Boehringer IngelheimJardiance$562$72,94851 claims
PfizerEliquis, Premarin, Paxlovid$206$63,845101 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$628$35,15648 claims
AbbVieLinzess, Synthroid$493$25,95390 claims
Johnson & JohnsonXarelto$19$15,96011 claims
GSKBreo Ellipta$374$4,90712 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 7,282 family medicine providers in Florida.

Other family medicine in St Petersburg

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →